Policy & Regulation
Raidium introduces AI-powered oncology imaging workflow for US cancer centres
17 July 2026 - AI-native radiology company Raidium announced on Thursday the US launch of Raidium Read (R.Read), applying its AI-native imaging solution initially to oncology research centres.Raidium ...
World Health Organization approves 'codabakalner' as International Nonproprietary Name for Spinogenix's SPG601
17 July 2026 - Clinical-stage biopharmaceutical company Spinogenix Inc announced on Thursday that the International Nonproprietary Names (INN) Expert Committee of the World Health Organization has app...
Circio and Avenue Biosciences launch research collaboration to improve protein secretion for gene therapy
16 July 2026 - Circio Holding ASA (OSE:CRNA), a biotechnology company developing novel circular RNA expression technology for gene and cell therapy, said on Thursday that it has entered into a researc...
Valerio Therapeutics signs R&D collaboration with Abivax and outlines pipeline milestones
16 July 2026 - Biotechnology company Valerio Therapeutics (Euronext Growth Paris:ALVIO) on Thursday announced a binding term sheet with Abivax for an exclusive global research and development collabor...
Lakewood-Amedex Biotherapeutics reports positive Nu-3 Gel preclinical safety data for upcoming Phase 2a trial
16 July 2026 - Clinical-stage biotechnology company Lakewood-Amedex Biotherapeutics Inc (NASDAQ:LABT) on Wednesday announced preclinical safety data for its Nu-3 gel formulation that establishes a str...
MAXONA Pharmaceuticals' Phase 2 clinical trial IND application for MAX-001 cleared by US FDA
16 July 2026 - Clinical-stage pharmaceutical company MAXONA Pharmaceuticals announced on Wednesday that the US Food and Drug Administration (FDA) has cleared the company's Investigational New Dru...